The Company listed on the Australian Securities Exchange in November 2013, following a reverse takeover of Eco Quest Ltd.
Level 3, 62 Lygon Street, Carlton, Victoria, Australia, 3053.
The share registry is managed by Automic Registry Services. To login and access your holding information, please go to: https://automic.com.au/.
All company shares are traded on the ASX and can be bought or sold through a licensed stock broker. The process of buying or selling shares is explained on the ASX website, please go to https://www.asx.com.au/products/shares/buying-selling-shares.htm
If you are an overseas investor, a licensed stock broker will be able to buy and sell shares listed on the ASX on your behalf. However, please check with your stock broker the markets that they participate in and make sure that Australia is one of them. Alternatively, online trading platforms offer solutions for overseas investors to invest in international equities.
All annual reports are available on our website through this link
Current share prices are available on the ASX website www.asx.com.au and can be searched using the Company’s ASX ticker symbol: CYP
Yes, recent research coverage can be found in the investor section of the website. Recent research has been published by Shaw and Partners, H.C Wainwright, NDF Research and Van Leeuwenhoeck Institute.
The ASX ticker code for the Company is ASX:CYP.
The share register is managed by Automic Registry Services. The registry provides a number of services which can be accessed online. When accessing some information online you may be required to enter your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements and other personal details such as your postcode.
To login and access your holding information, please go to: automic.com.au.
You can contact Automic here: automic.com.au/contact.html
The latest financial reports can be found on our website.
The Company’s end of financial year is the 30th of June.
A limited company is required to hold its annual general meeting within five months of its financial year end. Accordingly shareholders will be notified in the months of September or October, approximately 28 days in advance of when and where the AGM will be held. Typically, Cynata holds its AGM in mid November.
The Company’s auditor’s are Stantons International.
We may use personally-identifiable information to conduct research to improve health and care. As a biotechnology company, we have a legitimate interest in using information relating to the health and care of individuals for research studies, when those individuals agree to take part in a research study. This means that we will use individuals’ data, collected in the course of a research study, in the ways needed to conduct and analyse the research study. The rights of research subjects to access, change or move their information are limited, as we need to manage their information in specific ways in order for the research to be reliable and accurate. If research subjects withdraw from a study, we will keep the information about them that we have already obtained. To safeguard the rights of research subjects, we will use the minimum personally-identifiable information possible.
If you have participated in a Cynata-sponsored research study, and you wish to raise a complaint on how we have handled your personal data, you can contact us at firstname.lastname@example.org, and we will investigate the matter.
Our Corporate Governance policy can be found here: /corporate-governance. This includes our Board Charter, Code of Conduct, Diversity Policy, Continuous Disclosure Policy, Shareholder Communication Policy, Risk Management Policy and our Securities Trading Policy.
The Company does not currently have a dividend policy in place. It is the Company’s intention to fully commercialise its Cymerus platform and to reinvest any future profits in order to to grow the business. The Board reviews its growth strategy and dividend policies at regular meetings and assesses them against the Company’s working capital requirements and growth opportunities.